National survey on the susceptibility of Bacteroides fragilis group: Report and analysis of trends in the United States from 1997 to 2004

Antimicrobial Agents and Chemotherapy

Volumn 51, Issue 5, 2007, Pages 1649-1655

  Snydman, D R ^a,j   Jacobus, N V ^a   McDermott, L A ^a   Ruthazer, R ^a   Golan, Y ^a   Goldstein, E J C ^b   Finegold, S M ^c   Harrell, L J ^d   Hecht, D W ^e   Jenkins, S G ^f,g   Pierson, C ^h   Venezia, R ⁱ   Yu, V ^c   Rihs, J ^c   Gorbach, S L ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b R M Alden Research Laboratories   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

^e LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^f CAROLINAS MEDICAL CENTER   (United States)

^g MOUNT SINAI MEDICAL CENTER   (United States)

^h UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

ⁱ ALBANY MEDICAL CENTER   (United States)

^j TUFTS MEDICAL CENTER   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEFOXITIN; CHLORAMPHENICOL; CLINDAMYCIN; ERTAPENEM; IMIPENEM; MEROPENEM; METRONIDAZOLE; MOXIFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM; SULTAMICILLIN; TIGECYCLINE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTEROIDES FRAGILIS; BACTEROIDES OVATUS; BACTEROIDES THETAIOTAOMICRON; DATA ANALYSIS; GEOMETRY; NONHUMAN; PRIORITY JOURNAL; UNITED STATES;

ANTI-BACTERIAL AGENTS; BACTEROIDES; BACTEROIDES FRAGILIS; DRUG RESISTANCE, BACTERIAL; MICROBIAL SENSITIVITY TESTS; TIME FACTORS; UNITED STATES;

EID: 34248336950     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.01435-06     Document Type: Article

References (23)

1. Agresti, A. 1990. Categorical data analysis. John Wiley & Sons, Inc., New York, NY.
2. Aldridge, K. E., D. Ashcraft, K. Cambre, et al. 2001. Multicenter survey of the changing in vitro antimicrobial susceptibilities of clinical isolates of Bacteroides fragilis group, Prevotella, Fusobacterium, Porphyromonas, and Peptostreptococcus species. Antimicrob. Agents Chemother. 45:1238-1243.
3. Aldridge, K. E., and M. O'Brien. 2002. In vitro susceptibilities of the Bacteroides fragilis group species: change in isolation rates significantly affects overall susceptibility data. J. Clin. Microbiol. 40:4349-4352.
4. Betriu, C., E. Culebras, M. Gomez, I. Rodriguez-Avial, and J. J. Picazo. 2005. In-vitro activity of tigecycline against Bacteroides species. J. Antimicrob Chemother. 56:349-352.
5. Betriu, C., I. Rodriguez-Avial, M. Gomez, E. Culebras, E., and J. J. Picazo. 2005. Changing pasterns of fluoroquinolone resistance among Bacteroides fragilis group organisms over a 6-year period (1997-2002). Diagn. Microbiol. Infect. Dis. 53:221-223.
6. Brazier, J. S., S. L. Stubbs, and B. I. Duerden. 1999. Metronidazole resistance among clinical isolates belonging to the Bacteroides fragilis group: time to be concerned? J. Antimicrob. Chemother. 44:580-581.
7. Golan, Y., L. A. McDermott, N. V. Jacobus, et al. 2003. Emergence of fluoroquinolone resistance among the Bacteroides species. J. Antimicrob. Chemother. 52:208-213.
8. Golan, Y., et al. 2001. Abstr. 41st Intersci. Conf. Antimicrob. Agents Chemother., abstr. K1209.
9. Goldstein, E. J. C., D. M. Citron, Y. A. Warren, K. L. Tyrell, C. Vreni Merriam, and H. Fernandez. 2006. In vitro activity of moxifloxacin against 923 anaerobes isolated from human intra-abdominal infections. Antimicrob Agents Chemother. 50:148-155.
10. Hedberg, M., C. E. Nord, and the ESCMID Study Group on Antimicrobial Resistance in Anaerobic Bacteria. 2003. Antimicrobial susceptibility of Bacteroides fragilis group isolates in Europe. Clin. Microbiol. Infect. 9:475-488.
11. th ed. Virginia Polytechnic Institute and State University, Blacksburg.
12. Nakano, V., and M. J. Avila-Campos. 2004. Survey of antimicrobial susceptibility patterns of the bacteria of the Bacteroides fragilis group isolated from the intestinal tract of children. Mem. Inst. Oswaldo Cruz 99:319-324.
13. National Committee for Clinical Laboratory Standards. 2000. Methods for antimicrobial susceptibility testing of anaerobic bacteria, 5th ed. Approved standard. NCCLS publication no. M11-A5. National Committee for Clinical Laboratory Standards, Wayne, PA.
14. Nguyen, M. H., V. L. Yu, A. J. Morris, L. A. McDermott, M. W. Wagener, L. Hareell, and D. R. Snydman. 2000. Antimicrobial resistance and clinical outcome of Bacteroides bacteremia: findings of a multicenter prospective observational trial. Clin. Infect. Dis. 30:870-876.
15. Nichols, R. L., and J. W. Smith. 1993. Wound and intra-abdominal infections: microbiological considerations and approaches to treatment. Clin Infect. Dis. 16(Suppl. 4):S266-S272.
16. Oteo-Iglesias, J., J. I. Alos, and J. L. Gomez-Garces. 2002. Increase in resistance to new fluoroquinolones from 1998 to 2001 in the Bacteroides fragilis group. J. Antimicrob. Chemother. 50:1055-1057.
17. Paula, G. R., L. S. Falcao, E. N. Antunes, K. E. Avelar, F. N. Reis, M. A. Maluhy, M. C. Ferreira, and R. M. Dominguez. 2004. Determinants of resistance in Bacteroides fragilis strains according to recent Brazilian profiles of antimicrobial susceptibility. Int. J. Antimicrob. Agents 24:53-58.
18. Rokosz, A., J. Pawlowska, A. Sawicka-Grzelak, and M. Luczak. 2004. ESBL-positive strains of Bacteroides fragilis group isolated from patients at the regional hospital center in Plock (Poland). Med. Dosw. Mikrobiol 56:245-253.
19. Rosenblatt, J. E., and I. Brook. 1993. Clinical relevance of susceptibility testing of anaerobic bacteria. Clin. Infect. Dis. 16(Suppl. 4):S446-S448.
20. Snydman, D. R., G. J. Cuchural, L. McDermott, and M. Gill. 1992. Correlation of various in vitro testing methods with clinical outcomes in patients with Bacteroides fragilis group infections treated with cefoxitin: a retrospective analysis. Antimicrob. Agents Chemother. 36:540-544.
21. Snydman, D. R., N. V. Jacobus, L. A. McDermott, et al. 1999. Multicenter study of in vitro susceptibility of Bacteroides fragilis group, 1995 to 1996, with comparison of resistance trends from 1990 to 1996. Antimicrob. Agents Chemother. 43:2417-2422.
22. Snydman, D. R., N. V. Jacobus, L. A. McDermott, et al. 2002. National survey on the susceptibility of the Bacteroides fragilis group: report and analysis of trends for 1997-2000. Clin. Infect. Dis. 35(Suppl. 1):S126-S134.
23. Summanen, P., E. J. Baron, D. M. Citron, C. A. Strong, H. Wexler, and S. M. Finegold. 1993. Wadsworth anaerobic bacteriology manual, 5th ed. Star Publishing, Belmont, CA.